Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Kao

Concepts (371)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Heart Failure
34
2024
2065
5.210
Why?
Machine Learning
7
2024
516
2.240
Why?
Stroke Volume
17
2025
584
1.990
Why?
Adrenergic beta-Antagonists
10
2025
228
1.590
Why?
Methadone
5
2023
101
1.530
Why?
Pregnancy Complications, Cardiovascular
5
2022
79
1.470
Why?
Buprenorphine
3
2023
174
1.370
Why?
Cardiomyopathies
5
2022
325
1.360
Why?
United States Food and Drug Administration
5
2024
205
1.240
Why?
Decision Support Systems, Clinical
6
2024
242
1.220
Why?
Cardiomyopathy, Dilated
9
2025
334
1.160
Why?
Pharmacogenetics
5
2024
164
1.160
Why?
Adverse Drug Reaction Reporting Systems
4
2024
77
1.120
Why?
Arrhythmias, Cardiac
6
2023
328
1.100
Why?
Electronic Health Records
7
2024
1090
1.010
Why?
Cytochrome P-450 CYP2C19
4
2024
25
1.000
Why?
Propanolamines
3
2019
39
0.920
Why?
Hospitalization
10
2024
2228
0.890
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
448
0.870
Why?
Workflow
1
2024
165
0.810
Why?
Telemedicine
4
2024
876
0.790
Why?
Torsades de Pointes
4
2016
20
0.740
Why?
Seasons
1
2024
538
0.730
Why?
Pulmonary Edema
1
2021
114
0.710
Why?
Humans
85
2025
138972
0.700
Why?
Coffee
1
2021
16
0.690
Why?
Stroke
2
2021
1140
0.670
Why?
Pharmacogenomic Testing
4
2022
60
0.670
Why?
Defibrillators, Implantable
2
2021
305
0.650
Why?
Platelet Aggregation Inhibitors
1
2024
470
0.650
Why?
Aged
31
2025
24172
0.620
Why?
Prosthesis Failure
1
2020
123
0.600
Why?
Mobile Applications
1
2021
178
0.600
Why?
Long QT Syndrome
3
2016
67
0.600
Why?
Prosthesis-Related Infections
1
2020
99
0.600
Why?
Spironolactone
1
2019
34
0.590
Why?
Device Removal
1
2020
140
0.590
Why?
Pacemaker, Artificial
1
2020
116
0.580
Why?
United States
21
2024
15074
0.580
Why?
Mineralocorticoid Receptor Antagonists
1
2019
55
0.580
Why?
Medical Records
2
2019
183
0.570
Why?
Coronary Disease
1
2021
372
0.570
Why?
Biomedical Research
2
2024
695
0.560
Why?
Diabetes Mellitus
2
2024
1068
0.560
Why?
Periodicals as Topic
1
2020
211
0.550
Why?
Mortality
3
2019
360
0.550
Why?
Retrospective Studies
21
2024
15901
0.540
Why?
Risk Assessment
8
2024
3466
0.530
Why?
Hypertension, Pregnancy-Induced
1
2018
67
0.520
Why?
Female
48
2025
74016
0.510
Why?
Receptors, Transforming Growth Factor beta
1
2017
57
0.510
Why?
Hospital Records
1
2016
10
0.510
Why?
Atrial Fibrillation
3
2019
377
0.510
Why?
Ventricular Function, Left
5
2025
502
0.500
Why?
Proteoglycans
1
2017
109
0.500
Why?
Analgesics, Opioid
2
2023
1092
0.500
Why?
Hospital Mortality
6
2024
920
0.490
Why?
Artificial Intelligence
1
2019
293
0.480
Why?
Disease Management
1
2020
621
0.470
Why?
Survival
1
2015
39
0.470
Why?
Tetrazoles
1
2015
43
0.470
Why?
Middle Aged
29
2025
33782
0.460
Why?
Male
40
2025
68250
0.460
Why?
Biphenyl Compounds
1
2015
61
0.460
Why?
Muscle Proteins
2
2025
239
0.450
Why?
Myocardial Infarction
3
2018
1063
0.450
Why?
Research Design
1
2020
1120
0.420
Why?
Ventricular Remodeling
3
2025
257
0.420
Why?
Loperamide
2
2023
12
0.410
Why?
Registries
2
2020
2081
0.410
Why?
Myocardium
3
2017
921
0.410
Why?
Tachycardia, Ventricular
1
2015
172
0.400
Why?
Polymorphism, Single Nucleotide
4
2017
2138
0.400
Why?
Adult
28
2024
38393
0.400
Why?
Diet
1
2021
1285
0.390
Why?
Precision Medicine
6
2024
421
0.390
Why?
Legislation, Medical
1
2012
11
0.380
Why?
Amiodarone
1
2012
27
0.380
Why?
Peripartum Period
4
2022
22
0.380
Why?
Phenotype
5
2025
3143
0.370
Why?
Patient Readmission
1
2018
703
0.370
Why?
Quality Improvement
2
2020
1215
0.370
Why?
Anti-Arrhythmia Agents
1
2012
111
0.360
Why?
Catheter Ablation
1
2015
302
0.350
Why?
Sex Factors
4
2024
2050
0.350
Why?
Pyrazines
2
2008
86
0.340
Why?
Treatment Outcome
10
2025
10921
0.340
Why?
Heart Arrest
4
2019
383
0.340
Why?
Cardiovascular Diseases
5
2024
2058
0.340
Why?
Triazoles
2
2008
154
0.330
Why?
Forecasting
2
2024
384
0.330
Why?
Transfusion Reaction
1
2011
62
0.330
Why?
Heart-Assist Devices
1
2016
556
0.330
Why?
Echocardiography
3
2024
638
0.330
Why?
Postoperative Complications
2
2020
2716
0.320
Why?
Insurance, Health
1
2012
297
0.320
Why?
Patient Transfer
1
2012
178
0.310
Why?
Patient Discharge
2
2021
915
0.310
Why?
Databases, Factual
5
2020
1409
0.310
Why?
Anemia
1
2011
175
0.300
Why?
Risk Factors
9
2024
10385
0.300
Why?
Thiazolidinediones
1
2010
138
0.300
Why?
Aged, 80 and over
7
2024
7685
0.300
Why?
Genotype
3
2024
1849
0.300
Why?
Marketing
1
2008
32
0.290
Why?
Renal Insufficiency
1
2011
162
0.290
Why?
Rhabdomyolysis
1
2008
24
0.290
Why?
Simvastatin
1
2008
63
0.290
Why?
Heart Ventricles
4
2017
745
0.280
Why?
Receptors, Adrenergic, beta-1
4
2019
23
0.280
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2008
47
0.280
Why?
Heart Rate
3
2025
801
0.280
Why?
Length of Stay
4
2024
1237
0.280
Why?
Electrocardiography
4
2019
610
0.270
Why?
Cytochrome P-450 CYP2D6
3
2022
31
0.270
Why?
Drug Industry
1
2008
109
0.270
Why?
Kaplan-Meier Estimate
3
2016
897
0.270
Why?
Proportional Hazards Models
4
2021
1281
0.270
Why?
Practice Patterns, Physicians'
3
2020
1321
0.260
Why?
Pharmacovigilance
2
2024
23
0.260
Why?
Follow-Up Studies
6
2024
5152
0.250
Why?
Elective Surgical Procedures
2
2020
192
0.250
Why?
Incidence
5
2024
2830
0.250
Why?
Biological Specimen Banks
3
2024
100
0.250
Why?
Emergency Service, Hospital
2
2020
2114
0.240
Why?
Patient Reported Outcome Measures
2
2020
416
0.240
Why?
Gene Expression Regulation
1
2015
2591
0.230
Why?
Cause of Death
2
2019
433
0.230
Why?
Glucose
1
2010
1031
0.220
Why?
New York
1
2024
126
0.220
Why?
Diabetic Cardiomyopathies
1
2024
34
0.220
Why?
Pandemics
3
2022
1645
0.210
Why?
Young Adult
9
2022
13371
0.210
Why?
Pregnancy
6
2022
6870
0.210
Why?
Acute Kidney Injury
2
2008
812
0.210
Why?
Diphenoxylate
1
2023
5
0.210
Why?
Randomized Controlled Trials as Topic
3
2021
1522
0.200
Why?
Adolescent
10
2020
21581
0.200
Why?
Nonprescription Drugs
1
2023
64
0.190
Why?
Monitoring, Physiologic
1
2024
280
0.190
Why?
Heart Defects, Congenital
2
2020
850
0.190
Why?
Prognosis
5
2020
3995
0.190
Why?
Medicare
2
2020
792
0.190
Why?
Naltrexone
1
2023
102
0.190
Why?
Insulin Resistance
1
2010
1222
0.180
Why?
Time Factors
3
2020
6869
0.170
Why?
Speech
1
2021
71
0.170
Why?
Hypertension
2
2020
1249
0.170
Why?
Smartphone
1
2021
89
0.170
Why?
Red Meat
1
2021
20
0.170
Why?
Drug Dosage Calculations
1
2020
22
0.170
Why?
Losartan
1
2020
14
0.170
Why?
Lisinopril
1
2020
13
0.170
Why?
Data Interpretation, Statistical
2
2020
364
0.170
Why?
Cardiac Resynchronization Therapy
1
2021
40
0.170
Why?
Protective Factors
1
2021
96
0.170
Why?
Angioedema
1
2020
16
0.170
Why?
Actigraphy
1
2021
115
0.170
Why?
Wearable Electronic Devices
1
2021
52
0.170
Why?
Hypoglycemic Agents
1
2010
1343
0.170
Why?
American Heart Association
2
2019
293
0.170
Why?
Turner Syndrome
1
2021
52
0.170
Why?
Referral and Consultation
2
2017
795
0.160
Why?
Milk
1
2021
123
0.160
Why?
Biological Products
1
2023
226
0.160
Why?
Data Accuracy
1
2020
65
0.160
Why?
California
2
2012
438
0.160
Why?
Indans
1
2020
12
0.160
Why?
Oxadiazoles
1
2020
32
0.160
Why?
Editorial Policies
1
2020
51
0.160
Why?
Bionics
1
2019
14
0.160
Why?
Medical Futility
1
2019
27
0.160
Why?
Medical Informatics
1
2020
101
0.160
Why?
Software
2
2015
670
0.160
Why?
Fingolimod Hydrochloride
1
2020
40
0.160
Why?
Medical Record Linkage
1
2020
65
0.150
Why?
Information Storage and Retrieval
1
2020
118
0.150
Why?
Prescription Drugs
1
2020
112
0.150
Why?
Drug Overdose
1
2023
346
0.150
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2020
76
0.150
Why?
Drug Prescriptions
1
2021
260
0.150
Why?
Sitagliptin Phosphate
2
2008
33
0.150
Why?
Medical Order Entry Systems
1
2019
43
0.150
Why?
Child Health Services
1
2020
191
0.140
Why?
Social Determinants of Health
1
2022
260
0.140
Why?
Dose-Response Relationship, Drug
4
2020
2047
0.140
Why?
Cohort Studies
3
2021
5744
0.140
Why?
Tobacco Use
1
2019
65
0.140
Why?
Computer Graphics
2
2015
42
0.140
Why?
Cluster Analysis
1
2019
517
0.140
Why?
Gene Regulatory Networks
2
2023
310
0.140
Why?
Receptors, Histamine H2
1
2017
6
0.140
Why?
Advisory Committees
1
2019
218
0.140
Why?
Florida
1
2018
113
0.140
Why?
Neisseria gonorrhoeae
1
1997
25
0.130
Why?
Porins
1
1997
17
0.130
Why?
Dyslipidemias
1
2019
169
0.130
Why?
Prospective Studies
4
2021
7661
0.130
Why?
Nursing Assessment
1
2017
58
0.130
Why?
Academic Medical Centers
1
2020
513
0.130
Why?
Pressure Ulcer
1
2017
45
0.130
Why?
Heart Diseases
1
2020
336
0.130
Why?
Antihypertensive Agents
1
2020
503
0.130
Why?
Patient Participation
1
2020
428
0.130
Why?
Cardiology
1
2019
279
0.130
Why?
Population Surveillance
1
2020
482
0.130
Why?
Hospitals, Teaching
1
2017
115
0.130
Why?
Tilidine
1
2016
2
0.120
Why?
Double-Blind Method
3
2025
1949
0.120
Why?
Consensus
1
2019
683
0.120
Why?
Genetic Markers
1
2017
344
0.120
Why?
Oxycodone
1
2016
48
0.120
Why?
Databases, Genetic
1
2017
241
0.120
Why?
Rheumatic Heart Disease
1
2015
8
0.120
Why?
Sex Distribution
1
2016
380
0.120
Why?
Rheumatic Fever
1
2015
11
0.120
Why?
Cholesterol Ester Transfer Proteins
1
2015
18
0.120
Why?
Angiotensin II Type 1 Receptor Blockers
1
2015
38
0.120
Why?
Hospitals, Low-Volume
1
2015
23
0.110
Why?
Angiotensin II
1
2015
98
0.110
Why?
Gene Expression Profiling
3
2017
1746
0.110
Why?
Naloxone
1
2016
123
0.110
Why?
Immunosuppressive Agents
1
2020
848
0.110
Why?
Computational Biology
2
2017
650
0.110
Why?
Hospitals, High-Volume
1
2015
44
0.110
Why?
Oligonucleotide Array Sequence Analysis
1
2017
761
0.110
Why?
Marijuana Use
1
2018
206
0.110
Why?
Percutaneous Coronary Intervention
1
2020
488
0.110
Why?
Mothers
1
2020
765
0.110
Why?
United Kingdom
1
2015
321
0.110
Why?
Biomarkers
2
2024
4095
0.110
Why?
International Classification of Diseases
1
2015
138
0.110
Why?
Age Factors
2
2019
3276
0.110
Why?
Comorbidity
1
2019
1657
0.100
Why?
Chronic Disease
2
2020
1804
0.100
Why?
Gene Expression
2
2017
1487
0.100
Why?
Narcotic Antagonists
1
2015
186
0.100
Why?
Ventricular Dysfunction, Left
2
2020
365
0.100
Why?
Down-Regulation
1
2015
636
0.100
Why?
MicroRNAs
2
2017
676
0.100
Why?
Cholesterol
1
2015
403
0.100
Why?
Coronary Artery Disease
1
2019
695
0.100
Why?
Federal Government
1
2012
27
0.090
Why?
Myocytes, Cardiac
1
2017
513
0.090
Why?
RNA, Messenger
2
2017
2815
0.090
Why?
Drug Resistance
1
2012
149
0.090
Why?
Area Under Curve
1
2012
319
0.090
Why?
Genetic Predisposition to Disease
2
2017
2362
0.090
Why?
Predictive Value of Tests
1
2017
2030
0.090
Why?
Colorado
4
2024
4543
0.090
Why?
Opiate Substitution Treatment
1
2013
156
0.090
Why?
Patient Safety
1
2015
332
0.090
Why?
Gastrointestinal Hemorrhage
1
2012
130
0.090
Why?
Anti-Retroviral Agents
1
2013
244
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
1045
0.090
Why?
Pregnancy Outcome
1
2013
428
0.080
Why?
Survival Rate
1
2015
1934
0.080
Why?
Bayes Theorem
1
2012
413
0.080
Why?
Managed Care Programs
2
2022
140
0.080
Why?
Genome-Wide Association Study
1
2017
1391
0.080
Why?
Endoscopy, Gastrointestinal
1
2012
229
0.080
Why?
Delivery of Health Care
1
2017
963
0.080
Why?
Multivariate Analysis
1
2012
1497
0.070
Why?
Severity of Illness Index
1
2017
2849
0.070
Why?
Emergency Medical Services
1
2015
635
0.070
Why?
Pharmacogenomic Variants
2
2019
33
0.070
Why?
Drug Approval
1
2008
91
0.070
Why?
Primary Health Care
1
2019
1776
0.070
Why?
Vasodilator Agents
1
2010
329
0.070
Why?
Logistic Models
1
2012
2093
0.070
Why?
Kidney Function Tests
1
2007
156
0.070
Why?
Animals
3
2023
37243
0.060
Why?
Drug-Related Side Effects and Adverse Reactions
1
2008
253
0.060
Why?
Zimbabwe
2
2017
59
0.060
Why?
Drug Therapy, Combination
1
2008
1031
0.060
Why?
Opioid-Related Disorders
1
2013
546
0.060
Why?
Models, Biological
1
2012
1810
0.060
Why?
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels
1
2025
36
0.060
Why?
Case-Control Studies
1
2012
3574
0.060
Why?
Psychological Tests
1
2005
136
0.050
Why?
Osteoporosis, Postmenopausal
1
2004
42
0.050
Why?
Potassium Channels
1
2025
149
0.050
Why?
Mandible
1
2004
68
0.050
Why?
Cross-Sectional Studies
3
2022
5530
0.050
Why?
Depression
2
2022
1470
0.050
Why?
Receptors, Adrenergic
1
2023
21
0.050
Why?
Drug Administration Schedule
2
2020
769
0.050
Why?
Cardiovascular Agents
1
2025
156
0.050
Why?
Algorithms
3
2020
1730
0.050
Why?
Carcinoembryonic Antigen
1
2002
37
0.050
Why?
Antigens, Differentiation
1
2002
82
0.050
Why?
Child
5
2020
21936
0.050
Why?
Antigens, Bacterial
1
2002
125
0.040
Why?
Electronic Prescribing
1
2021
3
0.040
Why?
Cell Adhesion Molecules
1
2002
179
0.040
Why?
Vitamin K Epoxide Reductases
1
2020
11
0.040
Why?
Health Services Misuse
1
2020
33
0.040
Why?
Insurance Claim Reporting
1
2020
26
0.040
Why?
Antidepressive Agents
1
2022
245
0.040
Why?
Lymphocyte Count
1
2020
166
0.040
Why?
Morbidity
1
2020
321
0.040
Why?
Antigens, Neoplasm
1
2002
316
0.040
Why?
Membrane Glycoproteins
1
2002
501
0.040
Why?
Metoprolol
1
2019
25
0.040
Why?
Antineoplastic Agents
1
2010
2152
0.040
Why?
Grounded Theory
1
2019
36
0.040
Why?
Antigens, CD
1
2002
537
0.040
Why?
Aftercare
1
2020
215
0.040
Why?
Bias
1
2020
225
0.040
Why?
Genomics
1
2024
797
0.040
Why?
HIV Infections
1
2013
2945
0.040
Why?
Mice, Transgenic
1
2023
2171
0.040
Why?
Coronary Angiography
1
2020
317
0.030
Why?
Amino Acid Sequence
2
2002
2159
0.030
Why?
Delivery of Health Care, Integrated
1
2020
284
0.030
Why?
Static Electricity
1
1997
117
0.030
Why?
Exercise Test
1
2020
621
0.030
Why?
Molecular Sequence Data
2
2002
2925
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2017
95
0.030
Why?
Inpatients
1
2021
505
0.030
Why?
Focus Groups
1
2019
538
0.030
Why?
Frail Elderly
1
2017
129
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2017
348
0.030
Why?
Socioeconomic Factors
1
2020
1312
0.030
Why?
Puerperal Disorders
1
2016
31
0.030
Why?
Metabolic Networks and Pathways
1
2017
183
0.030
Why?
World Health Organization
1
2016
125
0.030
Why?
Physician-Patient Relations
1
2020
581
0.030
Why?
Neoplasms
1
2010
2687
0.030
Why?
Drug Combinations
1
2016
346
0.030
Why?
Decision Trees
1
2015
82
0.030
Why?
Data Mining
1
2015
116
0.030
Why?
Blood Pressure
1
2020
1737
0.030
Why?
Cell Membrane
1
1997
716
0.030
Why?
Biopsy
1
2017
1072
0.030
Why?
Pediatrics
1
2020
1079
0.020
Why?
Reproducibility of Results
1
2020
3313
0.020
Why?
Models, Genetic
1
2015
591
0.020
Why?
Liver
1
2020
1807
0.020
Why?
Infant
2
2015
9577
0.020
Why?
Mass Screening
2
2013
1296
0.020
Why?
Anthracyclines
1
2010
43
0.020
Why?
Child, Preschool
2
2015
11158
0.020
Why?
Trastuzumab
1
2010
96
0.020
Why?
Angiotensin Receptor Antagonists
1
2010
98
0.020
Why?
Signal Transduction
1
2023
5092
0.020
Why?
Clinical Trials as Topic
1
2015
1034
0.020
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2010
196
0.020
Why?
Program Evaluation
1
2013
917
0.020
Why?
Apoptosis
1
2017
2551
0.020
Why?
Injections, Intravenous
1
2007
202
0.020
Why?
Natriuretic Peptide, Brain
1
2007
98
0.020
Why?
Infusions, Intravenous
1
2007
411
0.020
Why?
Ultrasonography
1
2010
748
0.020
Why?
Mice
1
2023
17828
0.020
Why?
Creatinine
1
2007
485
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
814
0.010
Why?
Hospitals, University
1
2005
175
0.010
Why?
Dentists
1
2004
21
0.010
Why?
Femur Neck
1
2004
63
0.010
Why?
Bone Diseases, Metabolic
1
2004
64
0.010
Why?
Antibodies, Monoclonal
1
2010
1437
0.010
Why?
Absorptiometry, Photon
1
2004
263
0.010
Why?
Nurses
1
2005
189
0.010
Why?
Heparan Sulfate Proteoglycans
1
2002
25
0.010
Why?
Analysis of Variance
1
2004
1317
0.010
Why?
HeLa Cells
1
2002
638
0.010
Why?
Bone Density
1
2004
489
0.010
Why?
Binding Sites
1
2002
1317
0.010
Why?
Clinical Competence
1
2005
1149
0.010
Why?
Physicians
1
2005
930
0.010
Why?
Kao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)